Related Experiment Video
Updated: May 25, 2026

Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
Arginase II inhibition prevents nitrate tolerance
S M L Khong1, K L Andrews, N N Huynh
1Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Arginase II inhibition prevents nitrate tolerance by reducing reactive oxygen species (ROS) and endothelial nitric oxide synthase (eNOS) uncoupling. This finding offers a potential therapeutic strategy for improving nitrate efficacy.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Biochemistry
Background:
- Nitrate tolerance, a loss of vascular responsiveness, limits the therapeutic use of nitrates.
- Vascular superoxide, generated by uncoupled endothelial nitric oxide synthase (eNOS), is implicated in nitrate tolerance.
- Arginase competes with eNOS for L-arginine, potentially increasing reactive oxygen species (ROS) production.
Purpose of the Study:
- To investigate whether arginase inhibition can prevent or reduce nitrate tolerance.
- To explore the role of arginase II in the mechanisms underlying nitrate tolerance.
Main Methods:
- Vascular reactivity was assessed in mouse aorta using myography.
- eNOS uncoupling was evaluated by analyzing the eNOS monomer:dimer ratio.
- ROS levels were quantified using chemiluminescence assays.
Main Results:
- Arginase inhibition and arginase II knockout prevented nitrate tolerance in mouse aorta.
- Nitrate tolerance induction increased arginase activity and ROS production in wild-type mice.
- Arginase II deficiency or inhibition reduced eNOS uncoupling and ROS levels.
Conclusions:
- Arginase II plays a critical role in the development of nitrate tolerance.
- Inhibiting arginase II may be a viable strategy to overcome nitrate tolerance.
- Reduced eNOS uncoupling and ROS production are key mechanisms by which arginase inhibition prevents nitrate tolerance.
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Nitric Oxide Signaling Pathway
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Inorganic Nitrogen Assimilation
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors

